These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11421996)

  • 1. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man.
    Daley-Yates PT; Price AC; Sisson JR; Pereira A; Dallow N
    Br J Clin Pharmacol; 2001 May; 51(5):400-9. PubMed ID: 11421996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic profile of beclomethasone dipropionate hydrofluoroalkane after intranasal administration versus oral inhalation in healthy subjects: results of a single-dose, randomized, open-label, 3-period crossover study.
    Ratner PH; Melchior A; Dunbar SA; Tantry SK; Dorinsky PM
    Clin Ther; 2012 Jun; 34(6):1422-31. PubMed ID: 22621776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary pharmacokinetic methodology to determine the relative lung bioavailability of inhaled beclometasone dipropionate.
    Said AS; Harding LP; Chrystyn H
    Br J Clin Pharmacol; 2012 Sep; 74(3):456-64. PubMed ID: 22299644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the bioavailability and systemic effects of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler after single-dose administration in healthy male volunteers.
    Poli G; Acerbi D
    Respir Med; 2003 Feb; 97 Suppl B():S5-9. PubMed ID: 12593521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of particle size on lung deposition and pharmacokinetics of beclomethasone dipropionate in children.
    Agertoft L; Laulund LW; Harrison LI; Pedersen S
    Pediatr Pulmonol; 2003 Mar; 35(3):192-9. PubMed ID: 12567387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model.
    Daley-Yates PT; Richards DH
    Clin Ther; 2004 Nov; 26(11):1905-19. PubMed ID: 15639702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beclomethasone relative availability of oral versus inhaled beclomethasone dipropionate from an HFA-134A metered dose inhaler.
    Soria I; Harrison LI; Machacek JH; Cline AC; Stampone PA
    Biopharm Drug Dispos; 1998 Jul; 19(5):297-302. PubMed ID: 9673781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local versus total systemic bioavailability of beclomethasone dipropionate CFC and HFA metered dose inhaler formulations.
    Harrison LI
    J Aerosol Med; 2002; 15(4):401-6. PubMed ID: 12581506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of inhaled monodisperse beclomethasone as a function of particle size.
    Esposito-Festen JE; Zanen P; Tiddens HA; Lammers JW
    Br J Clin Pharmacol; 2007 Sep; 64(3):328-34. PubMed ID: 17439539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
    Fowler SJ; Orr LC; Wilson AM; Sims EJ; Lipworth BJ
    Br J Clin Pharmacol; 2001 Jul; 52(1):93-5. PubMed ID: 11453895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative kinetics of metabolism of beclomethasone propionate esters in human lung homogenates and plasma.
    Foe K; Brown KF; Seale JP
    J Pharm Sci; 2000 Sep; 89(9):1143-50. PubMed ID: 10944379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics.
    Seale JP; Harrison LI
    Respir Med; 1998 Jun; 92 Suppl A():9-15. PubMed ID: 9850358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of beclomethasone 17-monopropionate from a beclomethasone dipropionate extrafine aerosol in adults with asthma.
    Harrison LI; Kurup S; Wagner C; Ekholm BP; Larson JS; Kaiser HB
    Eur J Clin Pharmacol; 2002 Jun; 58(3):197-201. PubMed ID: 12107606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic comparison of beclomethasone dipropionate extrafine aerosol from two inhaler devices in children with asthma.
    Harrison LI; Kurup S; Chen LZ; Ekholm BP; Wighton TG; Shapiro GG
    Eur J Clin Pharmacol; 2002 Jun; 58(3):191-5. PubMed ID: 12107605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of Beclometasone From Two HFA-BDP Formulations With a Spacer.
    Said AS; AbuRuz S; Chrystyn H
    Respir Care; 2019 Oct; 64(10):1222-1230. PubMed ID: 31138731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of butixocort 21-propionate, budesonide, and beclomethasone dipropionate in the rat after intratracheal, intravenous, and oral treatments.
    Chanoine F; Grenot C; Heidmann P; Junien JL
    Drug Metab Dispos; 1991; 19(2):546-53. PubMed ID: 1676668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic exposure and implications for lung deposition with an extra-fine hydrofluoroalkane beclometasone dipropionate/formoterol fixed combination.
    Bousquet J; Poli G; Acerbi D; Monno R; Ramael S; Nollevaux F
    Clin Pharmacokinet; 2009; 48(6):347-58. PubMed ID: 19650674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of AeroChamber Plus™ on the lung and systemic bioavailability of beclometasone dipropionate/formoterol pMDI.
    Singh D; Collarini S; Poli G; Acerbi D; Amadasi A; Rusca A
    Br J Clin Pharmacol; 2011 Dec; 72(6):932-9. PubMed ID: 21615456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients.
    Singh D; Piccinno A; Borrill Z; Poli G; Acerbi D; Meuleners L; Woodcock A
    Pulm Pharmacol Ther; 2008; 21(3):551-7. PubMed ID: 18321744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of an extrafine fixed pMDI combination of beclometasone dipropionate/formoterol fumarate in adolescent asthma.
    Kuna P; Govoni M; Lucci G; Scuri M; Acerbi D; Stelmach I
    Br J Clin Pharmacol; 2015 Sep; 80(3):569-80. PubMed ID: 25808292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.